🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of study is to evaluate the current prevalence of HDV infection, an...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2022-01-01
Trial ID
NCT05264272
Treatments Being Tested
During their activation in response to an infectious stimulus or during chr...
Status
Completed
Location
Groupe Hospitalier Paris Saint-Joseph
Start Date
2020-11-19
Trial ID
NCT04594356
This randomized clinical trial studies the Beating Lung Cancer in Ohio prot...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2017-07-17
Trial ID
NCT03199651
The researchers are doing this study to measure and test cell-free DNA (cfD...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Start Date
2020-07-08
Trial ID
NCT04468841
A significant influence of the Herpes viruses family in the progression of ...
Status
Completed
Location
Malo Clinic
Start Date
2019-03-01
Trial ID
NCT05631288
Treatments Being Tested
BioGenParkinson is an observational, prospective cohort study evaluating bi...
Status
Unknown
Location
Multiple Locations
Start Date
2024-05-30
Trial ID
NCT05384522
Treatments Being Tested
The overall goal of this study is to inform the design and establish feasib...
Status
Not Yet Recruiting
Location
Botswana Harvard Health Partnership
Start Date
2026-06-01
Trial ID
NCT07576842
The purpose of this pragmatic cluster randomized control trial is to test t...
Status
Completed
Location
Uganda Cancer Institute
Start Date
2019-08-01
Trial ID
NCT04000503
Treatments Being Tested
The purpose of this study is to determine whether it is possible to predict...
Status
Terminated
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2011-05
Trial ID
NCT01855061
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested